Detalhe da pesquisa
1.
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.
Blood
; 141(26): 3166-3183, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084385
2.
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.
Cancer Immunol Immunother
; 73(1): 16, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236251
3.
Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.
Haematologica
; 108(11): 3011-3024, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345470
4.
Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.
Blood Cancer Discov
; 4(1): 54-77, 2023 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108149
5.
The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(18)2021 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572746
6.
Method for the Analysis of the Tumor Microenvironment by Mass Cytometry: Application to Chronic Lymphocytic Leukemia.
Front Immunol
; 11: 578176, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33193376
7.
The B-side of Cancer Immunity: The Underrated Tune.
Cells
; 8(5)2019 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086070